Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Does this stock interest you?
$ALQA Looking Good here still BAGGERS$$$$$$$
$ALQA 200MA & 50MA Touching @ $.051....
GO TIME!!!!
$$$ALQA Expecting another strong day tomorrow!!!
.05's Gone Now? Lol
$$$ALQA GIANT SALES EXEC DAVID JOHNSON$$$$
FROM MOST RECENT PR:
Mr. Johnson added, "This is a very exciting time to join the Alliqua team as we work together to increase revenues and build the Aquamed product portfolio to better serve the needs of the wound care market. I look forward to applying my industry knowledge and experience in building businesses and brands to further the success of Alliqua's marketed products and, ultimately, to increase shareholder value. From strategic collaborations to additive product or business acquisitions, I believe Aquamed is well positioned to pursue multiple significant opportunities in the wound care market."
(ALQA)"Alliqua" is a biopharmaceutical company focused on the development, manufacturing, and distribution of proprietary transdermal wound care and drug delivery technologies. Alliqua's leading technology platform produces hydrogels, a 3-dimensional cross-linked network of water soluble polymers capable of numerous chemical configurations. Alliqua currently markets its new line of 510K FDA-approved hydrogel products for wound care under the SilverSeal® brand.
ALQA ~ This is Solid Positive News for ALQA because this New Giant was Responsible for $1.6BB in Sales for ConvaTech, Inc... and he specialized in what ALQA has an FDA Product for which is Wound care products..
Why is this Appointment of David Johnson to ALQA Huge News??? Because he served as chief executive officer of ConvaTec Inc., a company with annual revenue of approximately $1.6 billion dedicated to the manufacture of acute and chronic wound care products, including antimicrobial ionic silver dressings.
Hmmmm....
I like Pie
$ALQA Strooooong-Strong Base in $.05-$.06
$ALQA MAJOR BREAKOUT AHEAD!!!!!
Sideways trading won't happen again until we get
into the teens IMO
The Stage is set.....
$ ALQA NICE CLOSE!!!!!
$ALQA $.062
$ALQA We should CRO$$ Tomorrow (if they don't hold her back.. THREE WHITE SOLDIERS ON THE HORIZON$$$$$$$
$ALQA MM's shuffling bid/ask
$ALQA That's right Olive Oil. ALQA Eating spinach $GREEEEEEEEEN!
Volume over 1mil. That's great NEWS!!!!!
$ALQA LOOKING GOOD, VERY GOOD...
$ALQA LOOKING VERY BULLISH
I know....this stock is showing me I have much more patience than I thought I had...
$ALQA I'm Good GREGG. I think announcing some type of Major Partnership or Sales Orders. That's where David Johnson and Zeldis come in. SAPIRSTEIN is playing the role of Tom Brady very nicely...
ALQA BIG MONEY
$$$$$$$$$$$$$$$$$$$
$ALQA Exactly.... I feel the same way Sir~
$ALQA NO Selling at the Bid Please......
$ALQA So close to that CROSS$$$$$$$$$$$$$$
$ALQA WALKING ON THE GREEN SIDE.... NICE
$ALQA LOOKING GOOD SO FAR!!!!!
$$$ALQA Nice Volume so far...
$ALQA $.06ASK
Nice Link!!!
$ALQA Or some nice Contracts $$$$$$
$ALQA~
LOOKING GOOD....
$ALQA SAWEEEEEEEEEEET!!!!!!!
$ALQA NICE....
$ALQA DAVID JOHNSON He most recently served as chief executive officer of ConvaTec Inc., a company with annual revenue of approximately $1.6 billion dedicated to the manufacture of acute and chronic wound care products, including antimicrobial ionic silver dressings
$$$$$$$$$$$
ALQA~
About Alliqua, Inc.
Alliqua, Inc. (ALQA) ("Alliqua") is a biopharmaceutical company focused on the development, manufacturing, and distribution of proprietary transdermal wound care and drug delivery technologies. Alliqua's leading technology platform produces hydrogels, a 3-dimensional cross-linked network of water soluble polymers capable of numerous chemical configurations.
Alliqua currently markets its new line of 510K FDA-approved hydrogel products for wound care under the SilverSeal® brand. Alliqua's electron beam production process, located at its 16,000 square foot GMP manufacturing facility in Langhorne PA, allows Alliqua to aggressively develop and custom manufacture a wide variety of hydrogels. Alliqua's hydrogels can be customized for various transdermal applications to address market opportunities in the treatment of wounds as well as the delivery of numerous drugs or other agents for pharmaceutical and cosmetic industries. Additionally, Alliqua's drug delivery platform, in combination with certain active pharmaceutical ingredients, can provide pharmaceutical companies with a transdermal technology to enhance patient compliance and potentially extend the patent life of valuable drug franchises. Additionally, our subsidiary, HepaLife Biosystems, Inc., focuses on the development of a cell-based bioartificial liver system, known as HepaMateâ„¢.
$ALQA Check it out.... "Dave's appointment to the position of executive chairman of our Aquamed subsidiary is an important step in Alliqua's evolution, as we strategically delineate the businesses within our organization," stated James Sapirstein, president and CEO of Alliqua. "While at ConvaTec Inc., Dave was responsible for an impressive increase in sales of its wound care product line through a number of strategic initiatives including investment in emerging markets, the launch of six new products in the past three years, and careful integration of acquisitions. These skills, as well as his diligent capital management and broad international experience, will serve Alliqua well as we make an effort to increase our position in the wound care market through licensing, acquisitions and other initiatives to build patient solutions to help drive Aquamed's value."
$$$$$$$$$$$$$$$$$$$$$$$$
$ALQA Mr. Johnson added, "This is a very exciting time to join the Alliqua team as we work together to increase revenues and build the Aquamed product portfolio to better serve the needs of the wound care market. I look forward to applying my industry knowledge and experience in building businesses and brands to further the success of Alliqua's marketed products and, ultimately, to increase shareholder value. From strategic collaborations to additive product or business acquisitions, I believe Aquamed is well positioned to pursue multiple significant opportunities in the wound care market."
ALQA~
$$$$$$$$$$$
Lol. What's up Balamidas? The clock is ticking...
$ALQA But the chart saysit all...
There has been but they have been moving it back down...
Waaaahhhhh! Lol
Nice Baggers$$$$$
$ALQA ~ Taking some time, but she is still a WINNNNNNNERRRRRR!!!!!
$ALQA
$ALQA is a Great stock, there is no denying that.
If this company fails I will stop investing. There is
just way too much potential for this to not do anything.
GO ALQA
$$$$$$$$$$$$$$$$$$$$$$$$